E
Translational Development Acquisition Corp. TDAC
$10.60 $0.000.00% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income 20,048.75% 2,808.16% 203,012.50% 185,487.50% 98.35%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1,337.61% -- -230,662.50% -228,912.50% --
Change in Net Operating Assets 106.61% 503.85% -- -- -45,480.00%
Cash from Operations 85.52% -117.53% -- -- --
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -26.74% -50.00% -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.94% -48.05% -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -108.13% -92.17% -589.43% -761.71% 107,150.00%